Research Institute

A Phase 2 Study of Alisertib in Patients with Extensive Small Cell Lung Cancer

A Phase 2 Study of Alisertib in Patients with Extensive Small Cell Lung Cancer

Disease Types: Lung

Available at: AlleghanyBlacksburgRoanokeSalemWytheville

A Phase 2 Study of Alisertib in Patients with Extensive Small Cell Lung Cancer

For More information:

https://clinicaltrials.gov/study/NCT06095505?term=A%20Phase%202%20Study%20of%20Alisertib%20in%20Patients%20with%20Extensive%20Small%20Cell%20Lung%20Cancer&rank=1